<?xml version='1.0' encoding='utf-8'?>
<document id="21886055"><sentence text="Physician perspective on propoxyphene as a potentially inappropriate medication in Tennessee."><entity charOffset="25-37" id="DDI-PubMed.21886055.s1.e0" text="propoxyphene" /></sentence><sentence text="Medicare Part D data from the Quality Improvement Organization's 9th Statement of Work drug safety indicator project under the direction of the Centers for Medicare &amp; Medicaid Services define the potentially inappropriate medications (PIMs) list for Tennessee" /><sentence text=" These data reveal propoxyphene as the main contributor to the state's PIM rate"><entity charOffset="19-31" id="DDI-PubMed.21886055.s3.e0" text="propoxyphene" /></sentence><sentence text=" In Tennessee, PIM and drug-drug interaction (DDI) rates indicate propoxyphene as the most prescribed medication among elderly patients despite decades of attention for potentially adverse effects"><entity charOffset="66-78" id="DDI-PubMed.21886055.s4.e0" text="propoxyphene" /></sentence><sentence text=" During this project, physicians agreed that PIM rates are too high, but disagreed in approach preference, i" /><sentence text="e" /><sentence text=", administrative limits and bans versus a proactive educational approach" /><sentence text=" Physicians were interested in participating in quality improvement by using individual pharmacy data to influence prescribing patterns" /><sentence text=" Exploring alternatives in research and survey, a potential and reachable point of intervention was found, a prescribing paradigm proposed by researchers to improve outcomes by reducing adverse effects in minimizing PIMs and DDIs" /><sentence text="" /></document>